Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor-κB-Dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways

Abstract

OBJECTIVE: To investigate whether inhibition of Akt phosphorylation by the phosphatidylinositol 3-kinase (PI3K) inhibitor, wortmannin, reduces metastasis and angiogenesis in a human breast cancer cell line via nuclear factor (NF)-κB-dependent matrix metalloproteinase (MMP)-9 and interleukin (IL)-8 pathways. METHODS: MDA-MB-231 cells were treated with wortmannin 0 – 200 nM for 4 h. Restoration of Akt activity was evaluated by transfection of cells with constitutively active myristoylated Akt (myr-Akt). NF-κB, MMP-9 and IL-8 proteins were detected by electrophoretic mobility shift assay, Western blot or enzyme-linked immunosorbent assay. The chicken embryo chorio-allantoic membrane assay, cell motility and migration assays were used to evaluate angiogenesis and invasion in vitro. A mouse pseudo metastatic breast cancer model was used to assess the effects of wortmannin on metastasis and angiogenesis in vivo. RESULTS: Wortmannin inhibited the phosphorylation of Akt, upregulation of NF-κB, MMP-9, IL-8, and in vitro cell invasion and angiogenesis, in a dose-dependent manner. Transfection of myr-Akt reversed the cellular and biochemical effects of wortmannin in vitro. Wortmannin also significantly inhibited tumour metastasis and angiogenesis in vivo. CONCLUSION: The findings of the present study suggest that wortmannin inhibits metastasis and angiogenesis in breast cancer cells via PI3K/Akt/NF-κB-mediated MMP-9 and IL-8 signalling pathways.

Keywords

WORTMANNIN BREAST CARCINOMA METASTASIS AKT NUCLEAR FACTOR-κB MATRIX METALLOPROTEINASE-9 INTERLEUKIN-8

References

Martelli

Evangelisti

Follo

: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr Med Chem 2011; 18: 2715–2726.

Dey

Bianchi

Voshol

: Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res 2010; 70: 4151–4162.

Adams

Phung

Yee

: Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res 2010; 70: 3594–3605.

Qiao

Sheng

Pardee

: Metastasis and AKT activation. Cell Cycle 2008; 7: 2991–2996.

Cheng

Chou

Kuo

: Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway. Oncogene 2006; 25: 7009–7018.

Osborn

Kunkel

Nabel

: Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989; 86: 2336–2340.

Chua

Hay

Rajendran

: Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. Biochem Pharmacol 2010; 80: 1553–1562.

Biswas

Lewis

: NF-κB as a central regulator of macrophage function in tumors. J Leukoc Biol 2010; 88: 877–884.

Prasad

Ravindran

Aggarwal

: NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 2010; 336: 25–37.

10.

Chen

Ling

: Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Toxicology 2011; 282: 122–128.

11.

Snoussi

Mahfoudh

Bouaouina

: Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 2010; 10: 283.

12.

Bendrik

Dabrosin

: Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo . J Immunol 2009; 182: 371–378.

13.

Yoo

Kim

: Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther 2008; 15: 635–651.

14.

Chavey

Mühlbauer

Bossard

: Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-κB pathway in breast cancer. Mol Pharmacol 2008; 74: 1359–1366.

15.

Végran

Boidot

Michiels

: Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 2011; 71: 2550–2560.

16.

Laezza

Malfitano

Di Matola

: Involvement of Akt/NF-κB pathway in N ⁶-isopentenyladenosine-induced apoptosis in human breast cancer cells. Mol Carcinog 2010; 49: 892–901.

17.

Yao

Cooper

: Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Nature 1995; 267: 2003–2006.

18.

Dignam

Lebovitz

Roeder

: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475–1489.

19.

Andrews

Faller

: A rapid micro-preparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499.

20.

Albini

Iwamoto

Kleinman

: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239–3245.

21.

Hua

Feng

Cao

: Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. Int J Oncol 2008; 33: 959–967.

22.

Sun

Wang

Paciga

: Akt1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001; 159: 431–437.

23.

Romashkova

Makarov

: NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86–90.

24.

Omar

Sargeant

Weng

: Targeting of the Akt-nuclear factor-κB signaling network by [1-(4-chloro-3-nitrobenzene-sulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma. Mol Pharmacol 2009; 76: 957–968.

25.

Lee

Hirani

Kyprianou

: Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells. Inflamm Res 2005; 54: 380–389.